OTCMKTS:CTYX Curative Biotechnology (CTYX) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CTYX Stock Alerts $0.03 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0350-Day Range$0.02▼$0.0452-Week Range$0.00▼$0.22Volume44,132 shsAverage Volume3.01 million shsMarket Capitalization$10.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Curative Biotechnology alerts: Email Address Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Curative BiotechnologyCurative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.Read More CTYX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTYX Stock News HeadlinesOctober 31, 2023 | tmcnet.comCurative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of DirectorsMay 17, 2023 | finance.yahoo.comCurative Announces Spin-Off of Sensible Diagnostics with their Game-Changing 10-Minute Point-Of-Care PCR Testing PlatformMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.May 16, 2023 | finance.yahoo.comSOLVE FSHD Invests in Epic Bio to Advance Potentially Curative TherapyJanuary 5, 2023 | wsj.comCurative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop StudyNovember 29, 2022 | msn.comAstraZeneca acquires biotech Neogene for $320M in bid to expand cancer treatmentsSeptember 12, 2022 | apnews.comArbor Biotechnologies Named One of Fierce Biotech’s “Fierce 15” Companies of 2022June 9, 2022 | apnews.com4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A FinancingSee More Headlines Receive CTYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Miscellaneous Health & Allied Services Sub-IndustryN/A Current SymbolOTCMKTS:CTYX CUSIPN/A CIKN/A Webwww.connectyx.com Phone(561) 418-7725FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares388,504,000Free FloatN/AMarket Cap$10.88 million OptionableNot Optionable Beta-33.99 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesPaul M. MichaelExecutive Chairman & PresidentI. Richard GarrChief Executive Officer & General CounselRon BordensExecutive VP-Technical Operations & ManufacturingBarry A. GinsbergVice Chairman & Chief Strategy OfficerKey CompetitorsIdeanomicsNASDAQ:IDEXForesight AutonomousNASDAQ:FRSXGopher ProtocolOTCMKTS:GOPHDIH Holding USNASDAQ:DHAIMaris-TechNASDAQ:MTEKView All Competitors CTYX Stock Analysis - Frequently Asked Questions How have CTYX shares performed in 2024? Curative Biotechnology's stock was trading at $0.0213 on January 1st, 2024. Since then, CTYX stock has increased by 31.5% and is now trading at $0.0280. View the best growth stocks for 2024 here. How do I buy shares of Curative Biotechnology? Shares of CTYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CTYX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.